Diseases of the Retina Practice Questions

Q: What is the commonest type of retinal detachment?

Rhegmatogenous. **Explanation:** **Rhegmatogenous Retinal Detachment (RRD)** is the most common type of retinal detachment encountered in clinical practice. The term is derived from the Greek word *rhegma*, meaning a "break." The underlying pathophysiology involves a full-thickness break (hole or tear) in the neurosensory retina. This allows liquefied vitreous to enter the subretinal space, separating the neurosensory retina from the underlying retinal pigment epithelium (RPE). The most common predisposing factor is **Posterior Vitreous Detachment (PVD)**. **Analysis of Incorrect Options:** * **Tractional RD:** The second most common type. It occurs when fibrovascular membranes (commonly in **Proliferative Diabetic Retinopathy**) pull the retina away from the RPE. There is no retinal break involved. * **Exudative (Serous) RD:** Occurs when fluid leaks into the subretinal space due to inflammation or vascular masses (e.g., Vogt-Koyanagi-Harada syndrome or posterior scleritis) without a break or traction. * **Choroidal Hemorrhage:** This is a complication (often surgical) involving bleeding in the suprachoroidal space; it is not a classification of retinal detachment itself. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors for RRD:** High myopia (most common association), aphakia, and lattice degeneration. * **Clinical Triad:** Photopsia (flashing lights), sudden onset of floaters, and a "curtain-like" loss of visual field. * **Shafer’s Sign:** The presence of "tobacco dust" (pigment cells) in the anterior vitreous is pathognomonic for a retinal tear. * **Management:** RRD is a surgical emergency. The goal is to seal the break using cryotherapy or laser photocoagulation, combined with procedures like scleral buckling or vitrectomy.

Q: What is the most common cause of macular edema?

Cataract surgery. **Explanation:** **Cataract surgery** is the most common cause of macular edema, specifically known as **Irvine-Gass Syndrome** (pseudophakic cystoid macular edema). The underlying mechanism involves the release of inflammatory mediators (prostaglandins) during surgery, which increase the permeability of the perifoveal capillaries, leading to fluid accumulation in the Henle’s layer of the retina. It typically peaks 4–6 weeks post-operatively. **Analysis of Incorrect Options:** * **Secondary Glaucoma:** While glaucoma involves high intraocular pressure that damages the optic nerve head, it does not typically cause macular edema. However, certain medications used to treat it (like Prostaglandin analogues) can induce CME. * **Retinitis Pigmentosa (RP):** CME is a known complication of RP (occurring in about 10-20% of cases), but it is far less common than post-surgical edema in the general population. * **Uveitis:** Inflammatory conditions of the eye frequently cause macular edema, but statistically, the sheer volume of cataract surgeries performed makes post-operative CME the more frequent clinical occurrence. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** **Optical Coherence Tomography (OCT)** is the investigation of choice (shows "honeycomb" cystic spaces). * **Classic Sign:** On **Fundus Fluorescein Angiography (FFA)**, it shows a characteristic **"Flower-petal appearance"** due to the radial arrangement of Henle’s layer. * **Management:** Prophylactic and therapeutic use of topical **NSAIDs** (e.g., Nepafenac or Ketorolac) is the first-line treatment. * **Other Causes:** Diabetic Retinopathy (most common cause of *vision loss* in diabetics) and Retinal Vein Occlusions (RVO).

Q: What is the drug of choice for the treatment of intermediate uveitis?

Steroids. **Explanation:** **Intermediate uveitis** is a chronic inflammatory condition primarily involving the vitreous and peripheral retina (pars plana). The mainstay of management for any non-infectious uveitis is the control of inflammation, making **Steroids (Option C)** the drug of choice. * **Why Steroids are Correct:** Steroids are potent anti-inflammatory agents that suppress the immune response. In intermediate uveitis, they are indicated when vision is threatened (usually <6/9) or if cystoid macular edema (CME) is present. Treatment typically follows a "stepladder" approach: starting with **Periocular (Sub-Tenon) injections** (e.g., Triamcinolone acetonide), followed by intravitreal implants or systemic steroids if the condition is bilateral or recalcitrant. * **Why other options are incorrect:** * **Cycloplegics (Option A):** While essential in *anterior* uveitis to prevent posterior synechiae and relieve ciliary spasm, they have no therapeutic role in the vitreous inflammation characteristic of intermediate uveitis. * **Analgesics (Option B):** Intermediate uveitis is typically **painless** (presenting with floaters and blurred vision); therefore, analgesics do not treat the underlying pathology. * **Antibiotics (Option D):** These are only indicated if an infectious etiology (like Syphilis or TB) is confirmed. Most cases are idiopathic or associated with systemic conditions like Sarcoidosis or Multiple Sclerosis. **Clinical Pearls for NEET-PG:** 1. **Snowballing/Snowbanking:** Classic clinical signs of intermediate uveitis (pars planitis). 2. **Cystoid Macular Edema (CME):** The most common cause of vision loss in these patients. 3. **Pars Planitis:** A subset of intermediate uveitis where "snowbank" formation occurs in the absence of an associated systemic disease. 4. **Side Effects:** Always monitor for steroid-induced glaucoma and cataracts during treatment.

Q: Pseudorosettes are characteristic histological findings in which of the following conditions?

Retinoblastoma. **Explanation:** **Retinoblastoma** is the most common primary intraocular malignancy of childhood. Histologically, it is characterized by the presence of **Flexner-Wintersteiner rosettes** (highly specific) and **Homer Wright pseudorosettes** [1]. * **Flexner-Wintersteiner Rosettes:** These consist of a ring of cuboidal cells surrounding a central lumen [1]. They are a sign of photoreceptor differentiation and are pathognomonic for retinoblastoma. * **Homer Wright Pseudorosettes:** These consist of tumor cells arranged around a central "tangled" hub of fibrils (neuropil) rather than a true lumen. While characteristic of retinoblastoma, they are also seen in other primitive neuroectodermal tumors like medulloblastoma and neuroblastoma. **Analysis of Incorrect Options:** * **B. Ophthalmia nodosa:** An inflammatory reaction caused by the hairs of certain caterpillars (caterpillar hair conjunctivitis). Histology shows granulomatous inflammation, not rosettes. * **C. Phacolytic glaucoma:** A secondary open-angle glaucoma caused by the leakage of lens proteins from a hypermature cataract. Histology shows macrophages laden with lens material (eosinophilic) in the anterior chamber. * **D. Trachoma:** A chronic keratoconjunctivitis caused by *Chlamydia trachomatis*. Histology reveals **Halberstaedter-Prowazek (HP) inclusion bodies** within epithelial cells. **NEET-PG High-Yield Pearls:** * **Flexner-Wintersteiner Rosettes** = True lumen (specific to Retinoblastoma) [1]. * **Homer Wright Pseudorosettes** = No lumen/fibrillar center (seen in Retinoblastoma, Neuroblastoma, Medulloblastoma). * **Perivascular Pseudorosettes:** Tumor cells arranged around a blood vessel (classic for **Ependymoma**) [2]. * **Clinical Sign:** The most common presenting sign of Retinoblastoma is **Leukocoria** (white pupillary reflex).

Q: What is the increased risk of blindness in a diabetic patient compared to a non-diabetic patient?

25 times. **Explanation:** **1. Why Option D is Correct:** According to epidemiological data and classic ophthalmology textbooks (such as Parsons' and Khurana), a person with diabetes mellitus is **25 times** more likely to suffer from legal blindness compared to a non-diabetic individual of the same age and sex. This significantly elevated risk is primarily due to **Diabetic Retinopathy (DR)**, which is a leading cause of preventable blindness worldwide. The pathology involves microvascular damage leading to capillary non-perfusion, ischemia-induced neovascularization (Proliferative DR), and macular edema. **2. Why Other Options are Incorrect:** * **Options A (5x) and B (10x):** These figures significantly underestimate the cumulative risk. While diabetes increases the risk of other ocular conditions (like cataracts) by 2–5 times, the overall risk of total blindness is much higher due to the irreversible nature of untreated retinal complications. * **Option C (15x):** While 15 times is a high risk, it does not reach the statistically established threshold of 25 times cited in standard medical literature for NEET-PG. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Duration of Diabetes:** This is the most important risk factor for the development of DR. After 20 years of diabetes, nearly 99% of Type 1 and 60% of Type 2 patients will show some signs of retinopathy. * **First Clinical Sign:** Microaneurysms (located in the inner nuclear layer). * **First Pathological Sign:** Loss of pericytes and basement membrane thickening. * **Classification:** DR is classified into Non-Proliferative (NPDR) and Proliferative (PDR). The hallmark of PDR is **Neovascularization** (NVD/NVE). * **Most Common Cause of Vision Loss:** Diabetic Macular Edema (DME) is the most common cause of decreased vision in NPDR, while Vitreous Hemorrhage and Tractional Retinal Detachment are major causes in PDR.

Q: The "smoke stack" pattern on optical coherence tomography is characteristic of which condition?

Central serous retinopathy. **Explanation:** **Central Serous Retinopathy (CSR)** is the correct answer. CSR is characterized by a localized serous detachment of the sensory retina at the macula, caused by leakage from the choriocapillaris through a defect in the Retinal Pigment Epithelium (RPE). The **"Smoke Stack" appearance** is a classic finding traditionally described in **Fluorescein Angiography (FFA)**. It occurs when fluorescein leaks through a small RPE opening and rises vertically (due to convection currents or pressure gradients) before spreading laterally in the subretinal space, resembling a plume of smoke. While the question mentions OCT, it is important to note that in clinical practice, "Smoke Stack" is the hallmark of FFA, whereas OCT typically shows a "dome-shaped" elevation of the neurosensory retina. **Analysis of Incorrect Options:** * **Sickle Cell Retinopathy:** Characterized by peripheral "Sea-fan" neovascularization and "Salmon-patch" hemorrhages, not smoke-stack leaks. * **Sarcoidosis:** Presents with "Candle-wax drippings" (perivascular exudates) and granulomatous uveitis. * **Acute Retinal Necrosis (ARN):** A viral infection (HSV/VZV) presenting with peripheral retinal whitening and rapid necrosis. **High-Yield Clinical Pearls for NEET-PG:** * **Demographics:** Typically affects young to middle-aged males with **Type A personalities** or those on **steroid therapy**. * **FFA Patterns:** "Smoke stack" (10%) and "Ink blot" (most common, 90%). * **OCT Finding:** Neurosensory detachment with or without Ped (Pigment Epithelial Detachment). * **Management:** Most cases are self-limiting; observation is the first line. If persistent, focal laser photocoagulation or PDT (Photodynamic Therapy) is used.

Q: What is the most common ophthalmic complication of diabetes mellitus?

Retinopathy. **Explanation:** **1. Why Retinopathy is the Correct Answer:** Diabetic Retinopathy (DR) is the most common microvascular complication of diabetes mellitus and the leading cause of blindness in the working-age population [1]. It occurs due to chronic hyperglycemia leading to basement membrane thickening, pericyte loss, and microaneurysm formation. Epidemiologically, nearly all patients with Type 1 Diabetes and >60% of patients with Type 2 Diabetes will develop some degree of retinopathy after 20 years of disease duration. **2. Analysis of Incorrect Options:** * **B. Cataract:** While diabetics develop cataracts earlier and more frequently (due to sorbitol accumulation in the lens via the polyol pathway), it is less common than the baseline incidence of retinopathy. * **C. Rubeosis iridis:** This refers to neovascularization of the iris. It is a late-stage complication usually secondary to severe proliferative diabetic retinopathy (PDR) and is much rarer than retinopathy itself [1]. * **D. Vitreous hemorrhage:** This is a specific complication of Proliferative Diabetic Retinopathy (PDR) caused by the rupture of fragile new vessels [1]. It is a consequence of advanced disease, not the most common finding. **3. High-Yield Clinical Pearls for NEET-PG:** * **Earliest Clinical Sign:** Microaneurysms (seen as red dots on fundoscopy) [1]. * **Earliest Pathological Sign:** Loss of pericytes and basement membrane thickening. * **Classification:** Divided into Non-Proliferative (NPDR) and Proliferative (PDR). The hallmark of PDR is **Neovascularization** [1]. * **Screening Guidelines:** * Type 1 DM: 5 years after diagnosis. * Type 2 DM: At the time of diagnosis (as the duration of hyperglycemia is often unknown). * **Most common cause of vision loss in DM:** Macular Edema (can occur at any stage of NPDR or PDR) [1].

Q: Mesencephalo-oculo-facial-angiomatosis is seen in which of the following conditions?

Wyburn-Mason syndrome. **Explanation:** **Wyburn-Mason Syndrome**, also known as **Bonnet-Dechaume-Blanc syndrome**, is a rare phakomatosis characterized by non-hereditary congenital arteriovenous malformations (AVMs). The hallmark of this condition is the presence of **racemose angiomas** involving the midbrain (mesencephalon), the retina (oculo), and occasionally the facial skin. This triad explains why it is termed **mesencephalo-oculo-facial-angiomatosis**. These AVMs do not typically pulsate or have a bruit, unlike other vascular malformations. **Analysis of Incorrect Options:** * **Klippel-Trenaunay-Weber Syndrome:** Characterized by a triad of port-wine stains, varicose veins, and bony/soft tissue hypertrophy, usually involving a single limb. It does not involve midbrain AVMs. * **Neurofibromatosis (NF1 & NF2):** NF1 is associated with Lisch nodules, café-au-lait spots, and neurofibromas. NF2 is characterized by bilateral vestibular schwannomas. Neither is defined by mesencephalic angiomatosis. * **Sturge-Weber Syndrome (Encephalotrigeminal Angiomatosis):** While it involves facial port-wine stains and leptomeningeal angiomas, the intracranial involvement typically affects the **cerebral cortex** (parieto-occipital region) rather than the midbrain, and it presents with "tram-track" calcifications. **Clinical Pearls for NEET-PG:** * **Key Imaging Finding:** "Bag of worms" appearance on angiography or MRI representing the racemose hemangioma. * **Clinical Presentation:** Patients often present with sudden vision loss (retinal hemorrhage) or neurological deficits/intracranial hemorrhage due to the midbrain AVM. * **High-Yield Association:** Unlike Sturge-Weber, Wyburn-Mason syndrome **lacks** cutaneous port-wine stains in most cases; facial involvement is usually via vascular nevi or small angiomas.

Q: What is the commonest cause of vision loss in non-proliferative diabetic retinopathy?

Macular edema. **Explanation:** In Diabetic Retinopathy (DR), vision loss occurs through different mechanisms depending on the stage of the disease. **Why Macular Edema is correct:** Macular edema (specifically Diabetic Macular Edema or DME) is the **most common cause of vision loss** in patients with **Non-Proliferative Diabetic Retinopathy (NPDR)**. It occurs due to the breakdown of the blood-retinal barrier, leading to the leakage of fluid and plasma constituents (like hard exudates) into the intraretinal layers of the macula. Since the macula is responsible for central, high-acuity vision, any thickening or edema here significantly impairs sight. **Analysis of Incorrect Options:** * **A. Vitreous Hemorrhage:** This is a hallmark complication of **Proliferative Diabetic Retinopathy (PDR)**, caused by the rupture of fragile new vessels (neovascularization). It is not a feature of NPDR. * **C. Detachment of the Retina:** Specifically, **Tractional Retinal Detachment** is a late-stage complication of PDR caused by fibrovascular proliferation. It does not occur in the NPDR stage. * **D. Subretinal Hemorrhage:** While it can occur in various retinal pathologies (like Wet AMD), it is not a primary or common cause of vision loss in NPDR. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of blindness in DR overall:** Diabetic Macular Edema (DME). * **Most common cause of sudden, painless vision loss in PDR:** Vitreous Hemorrhage. * **Earliest clinical sign of NPDR:** Microaneurysms (located in the inner nuclear layer). * **Investigation of choice for DME:** Optical Coherence Tomography (OCT) to measure retinal thickness. * **Standard Treatment for DME:** Intravitreal Anti-VEGF injections (e.g., Ranibizumab, Bevacizumab).

Question 1

Purtscher retinopathy is seen in patients with which of the following conditions?

Accepted Answer

Head trauma

Answer

Complication of chronic pancreatitis

Answer

Occlusion of the anterior retinal artery

Answer

Diabetes mellitus

Question 2

What is the commonest type of retinal detachment?

Accepted Answer

Rhegmatogenous

Answer

Choroidal hemorrhage

Answer

Exudative

Answer

Tractional

Question 3

What is the most common cause of macular edema?

Accepted Answer

Cataract surgery

Answer

Secondary glaucoma

Answer

Retinitis pigmentosa

Answer

Uveitis

Question 4

What is the drug of choice for the treatment of intermediate uveitis?

Accepted Answer

Steroids

Answer

Cycloplegics

Answer

Analgesics

Answer

Antibiotics

Question 5

Pseudorosettes are characteristic histological findings in which of the following conditions?

Accepted Answer

Retinoblastoma

Answer

Ophthalmia nodosa

Answer

Phacolytic glaucoma

Answer

Trachoma

Question 6

What is the increased risk of blindness in a diabetic patient compared to a non-diabetic patient?

Accepted Answer

25 times

Answer

5 times

Answer

10 times

Answer

15 times

Question 7

The "smoke stack" pattern on optical coherence tomography is characteristic of which condition?

Accepted Answer

Central serous retinopathy

Answer

Sickle cell retinopathy

Answer

Sarcoidosis

Answer

Acute retinal necrosis

Question 8

What is the most common ophthalmic complication of diabetes mellitus?

Accepted Answer

Retinopathy

Answer

Cataract

Answer

Rubeosis iridis

Answer

Vitreous hemorrhage

Question 9

Mesencephalo-oculo-facial-angiomatosis is seen in which of the following conditions?

Accepted Answer

Wyburn-Mason syndrome

Answer

Klippel-Trenaunay-Weber syndrome

Answer

Neurofibromatosis type 1 & 2

Answer

Sturge-Weber syndrome

Question 10

What is the commonest cause of vision loss in non-proliferative diabetic retinopathy?

Accepted Answer

Macular edema

Answer

Vitreous hemorrhage

Answer

Detachment of the retina

Answer

Subretinal hemorrhage

Diseases of the Retina — MCQs

Diseases of the Retina — MCQs

On this page

Practice by Chapter

Want unlimited practice?